Kringle Pharma, Inc. had a revenue of 17.96M in the quarter ending Jun 30, 2025, with 1.11%. This bring the company's revenue in the last twelve months to 72.40M, Increased -0.69%. In the fiscal year ending Dec 31, 2024, Kringle Pharma, Inc. had annual revenue of 80.04M with 15.58% growth.